Nitroimidazole: Phase I started

TB Alliance began a double-blind, placebo-controlled, single dose-escalation, U.S. Phase I trial in about 50 healthy male volunteers. TB Alliance licensed PA-824 from Chiron Corp. (CHIR, Emeryville, C...